InsiderClue
Stocks · Health care · Pharmaceutical Preparations

STANDARD BIOTOOLS INC.

LAB Clue Score34
United States Fiscal year ends December CIK 0001162194
$0.69 +2.85% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $0.69 −61.70% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 5 Apr 2022. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue104.4Operating income−73.2Net income−76.0Fiscal year 2017Revenue101.9 −2.4%Operating income−58.4Net income−60.5Fiscal year 2018Revenue113.0 +10.8%Operating income−48.2Net income−59.0Fiscal year 2019Revenue117.2 +3.8%Operating income−51.8Net income−64.8EPS, diluted−0.97Fiscal year 2020Revenue138.1 +17.8%Operating income−51.0Net income−53.0EPS, diluted−0.74Fiscal year 2021Revenue130.6 −5.5%Operating income−67.5Net income−59.2EPS, diluted−0.78Fiscal year 2022Revenue97.9 −25.0%Operating income−116.2Net income−190.1EPS, diluted−2.43Fiscal year 2023Revenue106.3 +8.6%Operating income−76.6Net income−74.7EPS, diluted−0.94Fiscal year 2024Revenue91.0 −14.4%Operating income−127.5Net income−138.9EPS, diluted−0.52Fiscal year 2025Revenue85.3 −6.2%Operating income−110.2Net income−74.9EPS, diluted−0.20
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 104.4 101.9 113.0 117.2 138.1 130.6 97.9 106.3 91.0 85.3
Growth −2.4% +10.8% +3.8% +17.8% −5.5% −25.0% +8.6% −14.4% −6.2%
Operating income −73.2 −58.4 −48.2 −51.8 −51.0 −67.5 −116.2 −76.6 −127.5 −110.2
Net income −76.0 −60.5 −59.0 −64.8 −53.0 −59.2 −190.1 −74.7 −138.9 −74.9
Growth
EPS, diluted n/a n/a n/a −0.97 −0.74 −0.78 −2.43 −0.94 −0.52 −0.20

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2016Gross margin55.9%Operating margin−70.1%Net margin−72.8%Free cash flow margin−42.3%Fiscal year 2017Gross margin51.0%Operating margin−57.3%Net margin−59.4%Free cash flow margin−25.2%Fiscal year 2018Gross margin54.6%Operating margin−42.6%Net margin−52.2%Free cash flow margin−22.6%Fiscal year 2019Gross margin54.8%Operating margin−44.2%Net margin−55.3%Free cash flow margin−32.2%Fiscal year 2020Operating margin−36.9%Net margin−38.4%Free cash flow margin−20.4%Fiscal year 2021Operating margin−51.7%Net margin−45.4%Free cash flow margin−43.9%Fiscal year 2022Gross margin37.8%Operating margin−118.6%Net margin−194.1%Free cash flow margin−95.1%Fiscal year 2023Gross margin47.4%Operating margin−72.0%Net margin−70.2%Free cash flow margin−43.4%Fiscal year 2024Gross margin49.3%Operating margin−140.1%Net margin−152.6%Free cash flow margin−166.8%Fiscal year 2025Gross margin49.9%Operating margin−129.2%Net margin−87.8%Free cash flow margin−96.9%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Gross margin 55.9% 51.0% 54.6% 54.8% n/a n/a 37.8% 47.4% 49.3% 49.9%
Operating margin −70.1% −57.3% −42.6% −44.2% −36.9% −51.7% −118.6% −72.0% −140.1% −129.2%
Net margin −72.8% −59.4% −52.2% −55.3% −38.4% −45.4% −194.1% −70.2% −152.6% −87.8%
Free cash flow margin −42.3% −25.2% −22.6% −32.2% −20.4% −43.9% −95.1% −43.4% −166.8% −96.9%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow−39.1Capital expenditure−5.1Free cash flow−44.2Fiscal year 2017Operating cash flow−24.1Capital expenditure−1.6Free cash flow−25.7Fiscal year 2018Operating cash flow−25.2Capital expenditure−0.4Free cash flow−25.6Fiscal year 2019Operating cash flow−35.2Capital expenditure−2.5Free cash flow−37.7Fiscal year 2020Operating cash flow−15.4Capital expenditure−12.7Free cash flow−28.1Fiscal year 2021Operating cash flow−44.1Capital expenditure−13.3Free cash flow−57.3Buybacks0.0Fiscal year 2022Operating cash flow−89.4Capital expenditure−3.8Free cash flow−93.2Buybacks−0.6Fiscal year 2023Operating cash flow−43.3Capital expenditure−2.8Free cash flow−46.1Buybacks−5.4Fiscal year 2024Operating cash flow−143.5Capital expenditure−8.4Free cash flow−151.8Buybacks−40.5Fiscal year 2025Operating cash flow−74.3Capital expenditure−8.3Free cash flow−82.6Buybacks0.0
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −39.1 −24.1 −25.2 −35.2 −15.4 −44.1 −89.4 −43.3 −143.5 −74.3
Capital expenditure −5.1 −1.6 −0.4 −2.5 −12.7 −13.3 −3.8 −2.8 −8.4 −8.3
Free cash flow −44.2 −25.7 −25.6 −37.7 −28.1 −57.3 −93.2 −46.1 −151.8 −82.6
Growth
Buybacks n/a n/a n/a n/a n/a 0.0 −0.6 −5.4 −40.5 0.0

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2016Cash35.0Shareholders’ equity53.2Fiscal year 2017Cash58.1Total debt195.2Net cash (debt)−137.2Shareholders’ equity30.9Debt to equity6.31Fiscal year 2018Cash95.4Shareholders’ equity72.1Fiscal year 2019Cash21.7Shareholders’ equity153.6Fiscal year 2020Cash68.5Shareholders’ equity139.1Fiscal year 2021Cash28.5Shareholders’ equity94.6Fiscal year 2022Cash81.3Total debt64.9Net cash (debt)16.4Shareholders’ equity−81.5Fiscal year 2023Cash51.7Total debt63.5Net cash (debt)−11.8Shareholders’ equity−148.1Fiscal year 2024Cash166.7Total debt0.3Net cash (debt)166.4Shareholders’ equity471.7Debt to equity0.00Fiscal year 2025Cash120.9Shareholders’ equity424.3
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 35.0 58.1 95.4 21.7 68.5 28.5 81.3 51.7 166.7 120.9
Total debt n/a 195.2 n/a n/a n/a n/a 64.9 63.5 0.3 n/a
Net cash (debt) n/a −137.2 n/a n/a n/a n/a 16.4 −11.8 166.4 n/a
Shareholders’ equity 53.2 30.9 72.1 153.6 139.1 94.6 −81.5 −148.1 471.7 424.3
Debt to equity n/a 6.31 n/a n/a n/a n/a n/a n/a 0.00 n/a

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024† 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
104.4 101.9 113.0 117.2 138.1 130.6 97.9 106.3 91.0 85.3
Growth −2.4% +10.8% +3.8% +17.8% −5.5% −25.0% +8.6% −14.4% −6.2%
0.3 50.0 51.3 53.0 n/a n/a 60.9 55.9 46.1 42.8
58.4 52.0 61.6 64.3 n/a n/a 37.1 50.5 44.9 42.5
Growth −11.0% +18.6% +4.3% +36.2% −11.0% −5.2%
38.4 30.8 30.0 31.6 36.5 37.9 37.4 25.9 28.8 26.0
93.2 79.5 79.8 84.5 97.9 98.9 102.3 87.5 103.1 109.9
−73.2 −58.4 −48.2 −51.8 −51.0 −67.5 −116.2 −76.6 −127.5 −110.2
Growth
−80.2 −63.8 −61.4 −66.7 −54.1 −63.7 −192.9 −74.2 −90.4 −96.7
−4.2 −3.3 −2.4 −1.9 −1.1 −4.4 −2.8 0.5 0.5 −37.9
−76.0 −60.5 −59.0 −64.8 −53.0 −59.2 −190.1 −74.7 −138.9 −74.9
Growth
Per share
n/a n/a n/a −0.97 −0.74 −0.78 −2.43 −0.94 −0.52 −0.20
n/a n/a n/a −0.97 −0.74 −0.78 −2.43 −0.94 −0.52 −0.20
Growth
n/a n/a n/a 66.8 72.0 75.8 78.3 79.2 353.2 381.6
n/a n/a n/a 66.8 72.0 75.8 78.3 79.2 353.2 381.6
Growth +7.9% +5.2% +3.3% +1.1% +346.2% +8.0%

† The diluted share count jumps at 2024, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue shrank 9.2% a year over five years.
  • Operating margin is down 92.3 points on five years ago, at -129.2%.
  • A net loss in 10 of 10 years on file.